Ann: Initial Results in First 16 DFU Patients Expected in Q1 2024, page-34

Stop obfuscating.

Real simple. You interrupted a thread on coming DFU results with capital raise FUD, on a day when the stock was nearly +50% on its high, likely on that coming event. And even went on to claim:

"you're delusional if you think CYP have enough funds to run the USA GVHD trial and keep the lights on at the same time"

No evidence or data to back up your baseless claim. I refuted with clear data/evidence from company metrics you clearly have not even bothered to read:

"CYP reports 12.6 qtrs of funding from its formal Appendix 4C - of course not as simple as that - closing the quarter with A$11.2m in cash and operating cash outflows, with the DFU trial in full flow, below $900K. The company itself has guided to at least 2025-26 FY in clearly stated allowance of GvHD trial costs. You might have noticed the DFU trial shortly coming to conclusion? Less R&D expenditure going forward?. LUMFC funding? Sculptor funding/full recruitment? No? You are all about GvHD, which the company has guided for ending enrolment in 2024CY - did you even read the reports? Its only a 60 patient trial with multiple sites and 6 already open for enrolment (3 USA / 3 Australia)."

You of course give no argument to your persistent claim of needing a capital raise and now call in others to join your trolling. Utterly childish. Go away troll.